Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

BACKGROUND AND AIMS: Immune checkpoint inhibitors (ICIs) exhibit significant clinical activity in patients with advanced hepatocellular carcinoma (HCC). This study explored whether tumor response to ICIs in HCC varies among different organs. METHODS: We reviewed the data of patients with advanced HC...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Liver Cancer
Main Authors: Lu, Li-Chun, Hsu, Chiun, Shao, Yu-Yun, Chao, Yee, Yen, Chia-Jui, Shih, I-Lun, Hung, Yi-Ping, Chang, Chun-Jung, Shen, Ying-Chun, Guo, Jhe-Cyuan, Liu, Tsung-Hao, Hsu, Chih-Hung, Cheng, Ann-Lii
Formato: Artigo
Idioma:Inglês
Publicado: S. Karger AG 2019
Assuntos:
Original Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6883443/
https://ncbi.nlm.nih.gov/pubmed/31799205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000501275
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares